At the present time there is no blood test to detect early stage ovarian cancer and no screening program.
GO Research Fund's major allocation is its commitment to the Ovarian Cancer Project, a collaboration between the Gynaecological Centre at the Royal Hospital for Women and the Cancer Research Program at the Garvan Institute of Medical Research. This brings together an internationally renowned treatment centre and an internationally renowned research centre.
The campaign is the only way we can continue with the vital research into ovarian cancer (often called "The Silent Killer") is to raise substantial funding. Ovarian cancer is the most fatal gynaecological malignancy. A woman dies every 10 hours from this disease. 850 women die of ovarian cancer every year in Australia.
Go Research is a sub-entity of the Royal Hospital for Women Foundation.
A research project to develop a blood-based screening test to diagnose ovarian cancer while it is still confined to the ovaries.